Zr-based metal–organic framework materials (Zr-MOFs) with increased specific surface area and pore volume were obtained using chemical (two materials, Zr-MOF1 and Zr-MOF3) and solvothermal (Zr-MOF2) synthesis methods and investigated via FT-IR spectroscopy, TGA, SANS, PXRD, and SEM methods. The difference between Zr-MOF1 and Zr-MOF3 lies in the addition of reactants during synthesis. Nitrogen porosimetry data indicated the presence of pores with average dimensions of ~4 nm; using SANS, the average size of the Zr-MOF nanocrystals was suggested to be approximately 30 nm. The patterns obtained through PXRD were characterized by similar features that point to well-crystallized phases specific for the UIO-66 type materials; SEM also revealed that the materials were composed of small and agglomerate crystals. Thermogravimetric analysis revealed that both materials had approximately two linker deficiencies per Zr6 formula unit. Captopril and ibuprofen loading and release experiments in different buffered solutions were performed using the obtained Zr-based metal–organic frameworks as drug carriers envisaged for controlled drug release. The carriers demonstrated enhanced drug-loading capacity and showed relatively good results in drug delivery. The cumulative percentage of drug release in phosphate-buffered solution at pH 7.4 was higher than that in buffered solution at pH 1.2. The release rate could be controlled by changing the pH of the releasing solution. Different captopril release behaviors were observed when the experiments were performed using a permeable dialysis membrane.
The synthesis and structural characterization of a new liquid crystalline coordination complex based on pentacoordinated Zn(II) metal centre with the coordination fulfilled by the tridentate chelating N^N^N 2,2′;6′,2″-terpyridine ligand and two monoanionic gallates decorated with several long alkyl chains is described. The mesomorphic properties were accurately investigated by small- and wide-angle X-ray scattering studies. Despite the bulky coordination around the metal centre, the complex self-organizes into a smectic phase and, based on the structural and geometrical parameters, a model for the supramolecular organization in the liquid crystalline phase is proposed. Electrochemical investigations showed the importance of the molecular structure of the coordination complex in enhancing its aqueous sensing capacities: the bulky organic ligands form an organic shell separating the metal centres and favouring the redox system through their reduction followed by stripping.
Recent experimental studies have proven the efficacy of targeting the acetohydroxyacid synthase (AHAS) enzyme against fungal and bacterial infections. Since AHAS is a vital enzyme for plants and microorganisms but absent in animals, it offers a highly selective target with a low risk of human toxicity. Our study aims to deepen the understanding of the molecular mechanisms involved in the inhibition of this enzyme (especially in the Candida albicans strain), as well as to extract the essential features responsible for the targeted biological activity. To this end, a suite of pharmacophore models was developed using integrated in silico methods. The approach included structure-based molecular docking techniques using the Glide module, and pharmacophore modeling via the Phase module. Structural hypotheses were built based on the specific interactions between a series of known inhibitors and key residues within the enzyme’s active site. As a result, an ensemble of 30 distinct pharmacophore hypotheses was generated, each configured to include between 3 and 5 pharmacophore features. The validation of these multiple models (including through atom-based QSAR methods and active-decoy analyses) demonstrated a high capacity to differentiate truly active compounds from inactive molecules. The obtained validated models can be successfully used as efficient filters in virtual screening campaigns for the discovery and optimization of novel compounds with high antifungal potential. This diversified approach maximizes the chances of identifying new efficient chemical structures while simultaneously guaranteeing an optimal safety profile.